Mayke B Hesselink

Title: Mayke B Hesselink: Innovator in Medicinal Chemistry

Introduction

Mayke B Hesselink is a prominent inventor based in Weesp, Netherlands. She has made significant contributions to the field of medicinal chemistry, particularly through her innovative work on phenylpiperazine derivatives. With a total of three patents to her name, Hesselink's inventions focus on developing compounds that have beneficial effects in treating various medical conditions.

Latest Patents

Hesselink's latest patents include a group of novel phenylpiperazine derivatives that exhibit a dual mode of action: serotonin reuptake inhibition and partial agonism on dopamine-D receptors. These compounds are designed for use in the manufacture of medicaments that provide therapeutic benefits. Additionally, she has worked on N-oxides of certain piperazine and piperidine derivatives, which are also aimed at treating central nervous system disorders. These disorders include anxiety, depression, schizophrenia, and Parkinson's disease, among others.

Career Highlights

Hesselink is currently employed at Solvay Pharmaceuticals B.V., where she continues to advance her research in medicinal chemistry. Her work has been instrumental in developing new therapeutic agents that address complex health issues.

Collaborations

Throughout her career, Hesselink has collaborated with notable colleagues, including Andrew C McCreary and Gustaaf J M Van Scharrenburg. These collaborations have further enriched her research and contributed to the success of her inventions.

Conclusion

Mayke B Hesselink is a distinguished inventor whose work in medicinal chemistry has the potential to significantly impact the treatment of various health conditions. Her innovative patents reflect her commitment to advancing medical science and improving patient outcomes.